Q4 2024 OncoCyte Corp Earnings Call Transcript

Author's Avatar
Mar 25, 2025


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OCX.OQ - OncoCyte Corp
Q4 2024 OncoCyte Corp Earnings Call
Mar 24, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome, everyone, and thank you for joining us to discuss OncoSite's 4th quarter 2024 results.

If you have not seen today's shareholder letter, please visit OncoSite.

Investor relations page at investors. OncoSite.com. Today's prepared remarks build upon the information already shared in this robust letter.

Joining us today are OncoSite President and CEO Josh Riggs, Chief Science Officer Ecky Schutz, and CFO Andrea James.

We also have our analysts with us as panelists. After our prepared remarks, our analysts may ask questions.

Attendees may also type questions into the Q&A.

Before turning the call over to Josh Riggs, I like to go over our safe harbor.

The company will make
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot